Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy
Medulloblastoma is the most common malignant brain tumor in children. Post-surgical craniospinal irradiation (CSI; 30-36 Gy) plus local boost radiation therapy (RT; 54-56 Gy) is a standard treatment for children with medulloblastoma who are over 3 years old, resulting in a 5-year overall survival (O...
Saved in:
相似書籍
-
Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy
由: Nongnuch Sirachainan, et al.
出版: (2018) -
Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy
由: Sirachainan N., et al.
出版: (2017) -
ADJUVANT CHEMOTHERAPY AND RADIATION IN MEDULLOBLASTOMA AFTER
SURGERY
由: Permono, Bambang, -
出版: (2023) -
Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide
由: Nongnuch Sirachainan, et al.
出版: (2019) -
Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis -retinoic acid in children with diffuse intrinsic pontine glioma
由: Nongnuch Sirachainan, et al.
出版: (2018)